Can a clinical trial fail because of poor protocol design? You can learn the answer in this episode which reviews a real life case of a clinical trial which failed because of its protocol design ..read more

This episode is about patients' involvement in clinical trials and the challenges and benefits for the industry of involving patients in the study design and review of patient facing materials. While it is easy to engage patients in academic and social research, there are some unique challenges for pharma and biotech companies ..read more

This episode is about the Research Ethics Committees in Europe and some of the challenges that they will face in the future. It also covers some of the existing challenges that everyone in the biotech and drug development industry faces when dealing with Ethics Committees. At the end, as always, there will be some recommendations how to improve the current practices and address the challenges ..read more

The extended access scheme allows patients to have early access to drugs which are not approved on the market but have shown potential in clinical trials. In the UK for the last 10 years were treated over 1,200 patients while in the USA just in 2022 were treated 2,417 patients. Why is that difference? You can learn more from this episode and what could be done to improve access to medications to more patients in the UK ..read more

This episode is dedicated to some of the main challenges that small pharma and biotech companies face. While funding is a critical one there are other issues like selecting the right consultants and vendors and optimising your clinical trials protocols in order to reduce your costs. There is a discussion on some options to optimise the cost of clinical trials ..read more

In this episode are summarised some of the main data protection challenges in artificial intelligence shared during the conference from Information Commissioner's Office ..read more

This episode is dedicated to IDEAL Framework and how it could be used to support surgical innovations. The episode is a brief overview of IDEAL and its classifications ..read more

This episode is dedicated on real work evidence (RWE) and the benefits and challenges of using such data in research and in support of marketing authorisations. I am also discussing how to improve the quality of real world data when designing your clinical trial ..read more

In this episode I will be talking about placebo clinical trials. I will discuss why we have placebo clinical trials; if they are ethical and what needs to be considered when designing such trials ..read more

In this episode I am discussing the recruitment challenges in clinical trials and how we can improve patients recruitment in clinical research ..read more